Articles, App Notes, Case Studies, & White Papers
-
How To Choose The Correct Syringe Filter For Analytical Sample Preparation
4/28/2022
This paper simplifies syringe filter selection and reviews the membranes and sizes required for specific analytical applications.
-
A Risk-Based Approach To Validation Studies For Sterilizing-Grade Filtration And Single-Use Systems
10/3/2024
One way to address risk related to product quality is by implementing a Question-Based Review approach. Read on to learn about this approach and its advantages.
-
Why Invest In Emerging Markets Now
10/10/2018
Unexplored and emerging markets are an attractive prospect for biopharma companies looking to expand. But when it comes to ensuring success, what’s the wisest way to invest?
-
IPF - Global Clinical Trial Landscape
5/19/2025
This report provides a comprehensive overview of Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal interstitial lung disease.
-
Non-Small Cell Lung Cancer — Global Clinical Trial Landscape (2024)
7/3/2024
Explore cutting-edge Non-Small Cell Lung Cancer (NSCLC) research with Novotech CRO's in-depth disease analysis, providing insights into innovative therapies, clinical trials, and future directions shaping NSCLC care globally.
-
Advancing Cell Therapies With Lipid Nanoparticles
3/24/2025
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
-
Best Practices For Analysis Of IVT mRNA
11/20/2025
Discover how an automated capillary electrophoresis system provides robust and precise integrity, concentration, and size analysis for IVT mRNA.
-
Evolution Of Clinical Trials In The Asia Pacific Region
9/22/2022
With changing global clinical trials landscape, explore how APAC is emerging as the hot spot for conducting clinical trials, especially in China.
-
Built Like A Tech Company: Why CROs Need A New Operating System
10/20/2025
See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.
-
Optimized Performance Model For Yield And Quality Of The mRNA Product
4/9/2024
Optimize your mRNA production by identifying an optimum set of conditions for the IVT reaction that produces high-quality mRNA in high yield using a design of experiment (DoE) approach.